C57BL/6 mice that are highly susceptible to infection with mouse hepatitis virus type 3 were protected against intraperitoneal viral infection by simultaneous intraperitoneal injection of Corynebacterium parvum. No protection was observed when C. parvum was given intravenously or when it was injected intraperitoneally 3 days before viral infection. Protective effects were, however, consistently found when C. parvum was given 2 h before or 2 h after viral infection. Activity was seen only against 10 50% lethal doses and not against 100 50% lethal doses. C. parvum also caused a significant decrease of virus yield in cultures of peritoneal exudate cells infected with mouse hepatitis virus type 3. These data suggest a direct effect of C. parvum on virus-susceptible cells. Injection of C. parvum in mice caused activation of natural killer (NK) cells and of interferon production. However, these two effects were equally demonstrable at high and low doses of C. parvum, whereas protection against mouse hepatitis virus type 3 was not demonstrable at low doses of C. parvum. Thus, antiviral protection may be dissociated from activation of NK cells and induction of interferon.
We have reported that a preparation of killed Corynebacterium parvum cells protected mice against lethal infection with herpes simplex virus (HSV) (10) . Similar observations have been made independently by other groups which treated various experimental viral infections with C. parvum or other bacteria, e.g., BacilleCalmette-Guerin (3, 6, 16, 22) . In our model, C. parvum had to be given several days before viral infection to achieve protection (13) . Recently, Budzko et al. (2) reported that C. parvum protected mice against Junin virus infection when the bacteria were given on the day of virus infection but that C. parvum injected before infection was not effective. In this paper, we present some data on the protective effect of C. parvum on mice infected with mouse hepatitis virus type 3 (MHV3). Similarly to the Junin Virus system, protection of NHV3-infected mice was achieved when C. parvum was administered simultaneously with the virus infection. lavage from the peritoneal cavity of C57BL/6 mice. They were cultivated as described above for virus titration but C. parvum was added to the experimental cultures in addition to MHV3. Viral titers were read after 4 days.
Activation of natural killer (NK) cells and induction of interferon production by injection of C parvum. Mice were injected with different doses of C. parvum, and after 24 h PEC were washed out and tested for both NK cell activity and interferon production with methods previously described (4 (8) , and maximal protection against HSV was observed when C. parvum was given 7 days before HSV (10) . Low levels of interferon could also be measured in the sera of mice 7 days after injection of C. parvum (13) .
However, it has been shown previously that mice injected with Corynebacterium acnes, bacteria which in their capacity to stimulate the lymphoreticular system of mice closely resemble C. parvum, have a decreased capacity to respond a Different doses of C. parvum were injected into C57BL/6 mice, and 10 LD5o of MHV3 were injected 2 h later. Parallel groups of mice were killed 18 h after injection of C. parvum, and PEC were recovered. Cells were pooled from five to seven mice and assayed for NK cell activity and interferon production.
b Number of dead mice per total number of mice injected with 10 LD5o of MHV3.
c Percent specific chromium release.
to interferon inducers (5) . In contrast, in recent studies from our laboratory it has been shown that the titers of serum interferon in mice injected 7 days previously with C. parvum and challenged with HSV do not differ from control mice that received HSV only (H. Kirchner, unpublished data). C. parvum represents one of the most powerful stimulants of the lymphoreticular system of mice (see reference 21 for a review). A multitude of effects on different cells of the lymphocytemacrophage system has been ascribed to the activity of C. parvum, e.g., activation of macrophages (7) and NK cells (17) . On the other hand, certain lymphocyte functions, such as mitogen responses or lymphocytotoxicity, were depressed in spleen cell cultures of C. parvum-treated mice (9, 11, 20) . Interestingly, 7 days after injection with C. parvum, NK cell activity was also depressed (18, 19) . We and others have therefore stressed that compounds such as C. parvum should be called immunomodulators since they have both suppressing and stimulatory capacities. However, protection against viral infections may represent immunopotentiation in a true sense.
The reasons why C. parvum protects mice from infection with MHV3 are not known. Two lines of evidence suggested that they are different from those that cause the previously described protection against HSV. First, protection could be observed when C. parvum was given simultaneously with MHV3, whereas under these conditions no protection was observed against HSV. Second, i.v. injection of C. parvum did not protect mice against MHV3 infection. However, protection against HSV occurred regardless of the route of C. parvum injection. Therefore, protection against HSV may be
caused by a systemic effect, whereas local effects may be predominant in the protection against MHV3.
Differences in genetic susceptibility and pathogenesis between HSV and MHV3 may be important in this context. C57BL/6 mice are resistant to infection with HSV (12, 14) , but highly susceptible to infection with MHV3 (1). Adult mice of strains susceptible to HSV infection die from encephalitis 7 to 10 days after i.p. infection (14) . In contrast, after i.p. infection with MHV3 adult mice die from fulminant hepatitis after 3 to 5 days (1).
Previously, it has been assumed that newborn, but not adult, mice are susceptible to HSV infection and that the resistance of adult mice was caused by the capacity of their macrophages to actively restrict HSV replication (23) . However, the situation appears to be more complex since it is now well established that adult mice of certain inbred strains are fully susceptible to HSV infection (12, 14) . Nevertheless, the percentage of macrophages that may be infected by HSV in vivo (in the peritoneal cavity) or in vitro appears to be very low (15, 23) . In contrast, MHV3 readily replicates to high titers in macrophages of genetically susceptible mice, such as C57BL/6, both in vivo and in vitro, and the replication in PEC seems to play the key role in the in vivo pathogenesis of the virus (1).
Presently, there are many possibilities to explain the protective effect of C. parvum against infection with MHV3. C. parvum induces interferon (8) and activates NK cells (18) . Its activating effect on macrophages has been established for some time (21) . In our laboratory we are probing these various effects of C. parvum, but their respective contribution to the protective effect of C. parvum against MHV3 remains to be further investigated. However, we have shown in this paper a clear-cut dissociation between antiviral protection on the one side and activation of NK cells and induction of interferon production on the other side. Low doses of C. parvum did not protect against MHV3 infection but yet efficiently induced these two defense mechanisms. Therefore, by exclusion, we tend to believe that C. parvum does not protect via one of these two mechanisms. Perhaps, and this conclusion is supported by our in vitro data, C. parvum protects by a direct effect on macrophages known to represent the targets of MHV3 replication (1, 24 
